CORC  > 吉林大学白求恩第三医院
Anagliptin ameliorates high glucose- induced endothelial dysfunction via suppression of NLRP3 inflammasome activation mediated by SIRT1
Jiang, Tiechao; Jiang, Dongli; Zhang, Lirong; Ding, Mei; Zhou, Hui
刊名MOLECULAR IMMUNOLOGY
2019
卷号107
关键词Type 2 diabetes mellitus Anagliptin NLRP3 infammasome SIRT1 Endothelial dysfunciton
ISSN号0161-5890
URL标识查看原文
语种英语
内容类型期刊论文
URI标识http://www.corc.org.cn/handle/1471x/3512077
专题吉林大学白求恩第三医院
推荐引用方式
GB/T 7714
Jiang, Tiechao,Jiang, Dongli,Zhang, Lirong,et al. Anagliptin ameliorates high glucose- induced endothelial dysfunction via suppression of NLRP3 inflammasome activation mediated by SIRT1[J]. MOLECULAR IMMUNOLOGY,2019,107.
APA Jiang, Tiechao,Jiang, Dongli,Zhang, Lirong,Ding, Mei,&Zhou, Hui.(2019).Anagliptin ameliorates high glucose- induced endothelial dysfunction via suppression of NLRP3 inflammasome activation mediated by SIRT1.MOLECULAR IMMUNOLOGY,107.
MLA Jiang, Tiechao,et al."Anagliptin ameliorates high glucose- induced endothelial dysfunction via suppression of NLRP3 inflammasome activation mediated by SIRT1".MOLECULAR IMMUNOLOGY 107(2019).
个性服务
查看访问统计
相关权益政策
暂无数据
收藏/分享
所有评论 (0)
暂无评论
 

除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。


©版权所有 ©2017 CSpace - Powered by CSpace